-
Register Now
-
Registration for this event is currently not available. For more information, please email support or call the Special Services number listed below.
Special Services
If you need assistance or have a special need related to attendance or meals, please notify the PD office at least two weeks prior to the conference.
Accreditation Information
The University of Kentucky, College of Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This education activity is offered for a maximum of 6.5 ANCC contact hours.
The Kentucky Board of Nursing (KBN) approves The University of Kentucky, College of Nursing (UKCON) as a provider as well. ANCC and KBN approval of a continuing nursing education provider does not constitute endorsement of program content nor commercial sponsors. The University of Kentucky does not approve commercial products. This education activity is offered for a maximum of 7.8 KBN contact hours. Provider #: 3-0008-12-23-0317. In order to receive credit, participants complete CNE activity, complete the evaluation form. Certificates may be printed once the evaluation is completed.
Objectives
- Describe pharmacology and patient outcomes associated with clinical use of select new drugs approved in 2022-2023.
- Discuss the pharmacology and indications for use, as well as dosage and administration considerations.
- List their common adverse reactions, contraindications and precautions for use.
- Discuss the practical considerations for use, and compare properties to those of older medications marketed for the same indications.
- Discuss updates in pain management and addiction disorders
- Discuss the changes in CDC guidelines for treatment of pain and their implications for practice.
Target Audience
The target audience for this activity are APRNs and RNs.
Faculty Disclosure
All faculty members participating in continuing education programs sponsored by the University of Kentucky College of Nursing are expected to disclose any real or perceived conflict of interest related to the content of their presentations. These presenters have nothing to disclose.
